Integrated Therapies for Alcohol use in Alcohol-associated Liver Disease (ITAALD)- Cleveland Clinic Clinical Center
Description: : Alcohol-associated liver disease (ALD) is a leading cause of mortality/morbidity, and there is no FDA-approved therapy for any stage of ALD. Unfortunately, patients with ALD rarely have their underlying alcohol use disorder (AUD) concomitantly addressed. This consortium links health providers with expertise in AUD and ALD in a unified treatment strategy to evaluate novel combined treatments for AUD/ALD in patients with advanced ALD. The exiting resources of the NIAAA-funded consortium are used for patient studies, biospecimen collection and site-specific translational studies.
Funding type: cooperative_agreement
Funder scheme: U01
Start date: 2018-08-01
End date: 2029-06-30
Investigator: SRINIVASAN DASARATHY
Institution: CLEVELAND CLINIC LERNER COM-CWRU
Funded outputs count: 72
Funder award ID: U01AA026976
OpenAlex ID: G9000907749